Navigation Links
'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down
Date:11/6/2007

."

Constipation, one of the most common digestive complaints in the U.S., affects up to 42 million adults, and is more prevalent in women than men. Based on a retrospective analysis, it is estimated that 12 million can be characterized as suffering from Chronic Idiopathic Constipation. Chronic Idiopathic Constipation is chronic constipation with no known cause. Older adults age 65 years and older are especially susceptible to constipation.

AMITIZA, developed by Sucampo Pharmaceuticals, is the first and only chloride channel activator for the treatment of Chronic Idiopathic Constipation in adults, regardless of age or gender. AMITIZA has a unique mechanism of action that may provide predictable relief to help people with Chronic Idiopathic Constipation.

For additional background about AMITIZA and Chronic Idiopathic Constipation, please log onto http://www.amitizapresskit.com.

About AMITIZA(R) (lubiprostone) 24 mcg BID for Chronic Idiopathic Constipation

AMITIZA(R) (lubiprostone) is indicated for the treatment of Chronic Idiopathic Constipation in adults.

AMITIZA is contraindicated in patients with known mechanical gastrointestinal obstruction. Patients with symptoms suggestive of mechanical gastrointestinal obstruction should be thoroughly evaluated by the treating physician to confirm the absence of such an obstruction prior to initiating AMITIZA treatment.

The safety of AMITIZA in pregnancy has not been evaluated in humans. In guinea pigs, lubiprostone has been shown to have the potential to cause fetal loss. AMITIZA should be used during pregnancy only if the benefit justifies the potential risk to the fetus. Women who could become pregnant should have a negative pregnancy test prior to beginning therapy with AMITIZA and should be capable of complying with effective contraceptive measures.

Patients taking AMITIZA may experience nausea. If this occurs, concomi
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc. and Sucampo
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
2. ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
3. Mediatech Moves to Prince William County Innovation Park
4. FDA Removes Partial Hold on TELCYTA Clinical Development
5. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
6. BioSpace and BayBio Launch 11th Edition of Biotech Bay(TM) Hotbed Map Campaign
7. BioSpace, 2008 BIO International Convention and BIOCOM Launch 9th Edition of Biotech Beach Hotbed Map Campaign
8. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
9. Homewatch CareGivers Launches 2007 We Care For Veterans Campaign
10. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
11. Nanowire generates power by harvesting energy from the environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...
(Date:12/14/2009)... Dec. 14 The third edition of ... , published by the Infusion Nurses ... for anthracycline extravasation.(1) Anthracyclines are a group ... epirubicin that have been used in the treatment ... 1970s.(2) ,, According to the INS ...
(Date:12/14/2009)... completed the delivery of Brookfield Engineering’s Powder Flow Tester – ... with a smaller footprint and more compact design. , ... ... -- ThermoFab, a US-based thermoforming company, has completed the delivery ... from sheet metal to a plastic enclosure with a smaller ...
(Date:12/11/2009)... 2009 -- Researchers have discovered a new explanation for differences ... excess copies of a certain gene, the more serious the ... it is suspected that it is the amount of copies ... being published in the American Journal of Human Genetics ... of Guy Froyen connected to VIB, a life sciences research ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2
... Vista Partners announced,today that it has updated its ... ) and maintains its twelve month target price ... Partners stated, "Sales,internationally continue to increase and sales ... in numerous testing centers, continue,to increase as well. ...
... March 31 Chem Rx,Corporation (OTC Bulletin Board: ... services, announced today that it has postponed its,conference ... 2008 outlook,that was originally scheduled for April 1, ... timing of the 2007 financial results press release ...
... Bald has demonstrated that hydrogen can be efficiently stored ... easily used in mobile applications. Bald discovered that 30 ... the favourable extraction and storage of hydrogen possible. ... and transport medium for energy. Therefore many future scenarios ...
Other Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results 2
(Date:12/14/2009)... of the United Nations Framework Convention on Climate ... Agency hosted the ,Bend the Trend, event on ... platform and premiere the screening of the new ... of Europe, a joint project of the European ... and ESA, is a series of short films ...
(Date:12/13/2009)... enzymes that may help to engineer plants that take ... efficiently. The finding could help to engineer crops that ... in the carbon dioxide they need for photosynthesis through ... for each molecule of the gas gained, they lose ... pores can tighten to save water when CO 2 ...
(Date:12/13/2009)... are associated with the health of the human lung. ... from 63 centres in Europe and Australia sheds new ... The new findings provide hope for better treatment for ... asthma. In the past it has been difficult to ... the health of the lung are not completely understood. ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3New genes for lung disease discovered 2JourneyLite of Houston Receives Center of Excellence Accreditation 49400 1JourneyLite of Houston Receives Center of Excellence Accreditation 49400 2JourneyLite of Houston Receives Center of Excellence Accreditation 49400 3Transition Therapeutics Announces Appointment of Vice President of Clinical Operations 49398 1Transition Therapeutics Announces Appointment of Vice President of Clinical Operations 49398 2HealthSouth Comments on Civil Litigation 49395 1HealthSouth Comments on Civil Litigation 49395 2
... mysteries. So it's a delicious irony that the next big ... , "Molecules are fossils, too," said Michigan State University ... old fossils, and proteins can tell us about diseases, about ... ate and who they are related to." , Ostrom joins ...
... and Infectious Diseases (NIAID), part of the National Institutes ... anthrax toxin that worked well in small-scale animal tests. ... anthrax antitoxin is an important advance, not only for ... also because this technique could be used to design ...
... in the brain that appears to trigger the brain ... offer an important target for drugs to treat addiction ... in the February 16, 2006, issue of Neuron, Antonello ... peptide, called orexin A acts on a brain region ...
Other Biology News:Next good dinosaur news likely to come from small packages 2Scientists design potent anthrax toxin inhibitor 2Scientists design potent anthrax toxin inhibitor 3How the brain learns to become addicted 2
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
... template is designed to allow neomycin/kanamycin ... The loxP-PGK-gb2-neo-loxP template encodes the ... prokaryotic promoter (gb2) for expression of ... eukaryotic promoter (PGK) for expression of ...
... precision 5mm diameter, 7 inch long PYREX NMR ... compatibility with ground joints, valves, and vacuum racks. ... running from 300 to 500MHz. They have an ... of 4.20 + 0.013-0.000mm. These NMR tubes can ...
Biology Products: